Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies reported a record annual revenue of $920 million for 2022, a 39% increase from $662.4 million in 2021. The company's gross margin improved to 43.7% while net income rose to $183.1 million, or $5.46 per diluted share, reflecting an 86% year-over-year increase. For Q4 2022, revenue was $266.1 million, with a gross margin of 41.2%. Looking ahead, Axcelis expects first-quarter revenue of approximately $240 million and over $1 billion for the full year 2023. The company also introduced a new revenue model projecting $1.3 billion in the next 2-3 years.
Axcelis Technologies (Nasdaq: ACLS), a leader in semiconductor solutions, announced that its President and CEO, Mary Puma, has been elected Chairperson of the International Board of Directors of SEMI. This significant role allows her to lead the evolution of SEMI's operations and services globally. Puma, who has served on the SEMI board since 2003, aims to address the challenges and opportunities facing equipment and materials companies in the semiconductor technology supply chain. The SEMI board comprises representatives from various regions, including Europe, China, and North America, reflecting its global reach.
Axcelis Technologies, Inc. (Nasdaq: ACLS), a key player in the semiconductor industry, announced follow-on shipments of its Purion H™ high current implanters to various fabs. This development supports the ramp-up of advanced logic device technology manufacturing. Shipped in Q4 2022, these systems provide unmatched levels of process control, throughput, and uniformity, enabling chip manufacturers to enhance yield while minimizing ownership costs. Executive Vice President Greg Redinbo highlighted the innovative architecture of the Purion H, designed specifically for advanced memory and logic applications.
Axcelis Technologies (Nasdaq: ACLS) will showcase its Purion™ platform at SEMICON Korea 2023 from February 1-3 at COEX Center, Seoul. This event highlights their cutting-edge ion implanters including the Purion H™ Series, Purion XE™ Series featuring patented Boost Technology™, and the Purion Power Series designed for diverse wafer types. The company emphasizes its in-country manufacturing capabilities and local supply chain in Korea, a key market in the Asia Pacific region. President and CEO Mary Puma highlighted the importance of delivering advanced technology to Korean chipmakers.
Axcelis Technologies, Inc. (NASDAQ: ACLS) announced significant shipments of its Purion Power Series™ ion implanter systems to silicon carbide (SiC) power device manufacturers across Asia, Europe, and the U.S. These advanced systems, including the Purion H200™, Purion XE™, and Purion M™, support high-volume production for electric vehicle applications. The company forecasts that power device shipments will account for 35% to 40% of total system shipments in 2022, with further growth anticipated in 2023. CEO Mary Puma noted the rapid growth in the SiC power device market, driven by the shift toward electric vehicles.
Axcelis Technologies (Nasdaq: ACLS) will announce its 2022 financial results on February 8, 2023, at 4:00 PM ET. A subsequent conference call to discuss these results will take place on February 9, 2023, at 8:30 AM ET. Investors can access the call via an audio webcast on the company's website. Axcelis has been a key player in providing high-productivity solutions for the semiconductor industry for over 40 years, focusing on ion implantation systems, which are critical in integrated circuit manufacturing.
Axcelis Technologies reported strong financial guidance for Q4 2022, anticipating revenue exceeding $250 million, surpassing previous estimates of $232-$240 million. For the full year 2022, revenue is expected to exceed $900 million, with earnings per diluted share anticipated to be over $1.45 in Q4 and exceed $5.00 for the full year. CEO Mary Puma emphasized robust customer demand for the Purion product family, hinting at year-over-year growth in 2023, supported by favorable foreign exchange impacts on earnings.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 25th Annual Needham Growth Conference, scheduled for January 10-11, 2023, at the Lotte New York Palace Hotel and virtually on January 12, 2023. The company will present on January 11th at 2:15 p.m. EST, with management available for one-on-one meetings. A live webcast will be accessible from Axcelis' website, with a replay available for 30 days after the event. Axcelis has been a key player in the semiconductor industry for over 40 years, focusing on ion implantation systems.
Axcelis Technologies (Nasdaq: ACLS) announced multiple shipments of the Purion Dragon™ high current implanter, including a follow-on order and a new customer evaluation aimed at semiconductor manufacturers in Asia. These shipments are part of Q4 2022 activities and support advanced memory and logic device development. Executive VP Greg Redinbo emphasized the Purion Dragon's capabilities, highlighting its advanced process control and productivity gains for high current applications. This move reinforces Axcelis' commitment to innovation in the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) will showcase its innovative Purion and GSD Ovation Series ion implanters at SEMICON Japan 2022, held from December 14-16 in Tokyo. The event aims to highlight technologies that support power device, image sensor, memory, and logic markets. Key products include the Purion Power Series for silicon processing and the Purion XE Series with Boost Technology for advanced image sensors. Axcelis aims to expand its market share in Japan by meeting the increasing demand from chipmakers with these advanced solutions.